Remedium Retatrutide 50mg Pen is a laboratory-grade peptide research formulation developed for advanced metabolic and body-composition studies involving triple agonist pathway interaction.

Retatrutide is commonly examined in research environments for its interaction with:

• GLP-1 receptor pathways
• GIP receptor signalling
• Glucagon receptor activity
• Appetite-regulation mechanisms
• Energy-expenditure pathways

This 50mg prefilled pen system is designed for controlled laboratory applications requiring accurate dosing and high-purity peptide formulations.

The Remedium Research FlexiPen delivery system provides convenient multi-dose administration for ongoing experimental protocols and metabolic-response observation studies.

Key Features

• 50mg high-strength Retatrutide formulation
• Triple agonist peptide research compound
• Prefilled FlexiPen delivery system
• Commonly studied for metabolic pathway analysis
• Designed for body-composition and appetite-regulation research
• Precision multi-dose research pen

How to Use (Research Reference Only)

This product is intended strictly for laboratory and scientific research conducted by qualified professionals using controlled research protocols.

Not intended for human consumption.

Research Applications

Retatrutide research commonly focuses on:

• Experimental metabolic regulation studies
• Appetite-response pathway observation
• Energy-balance modelling
• GLP-1 and GIP signalling research
• Body-composition analysis
• Longevity and metabolic-efficiency studies

Package Contents

• 1 x 3ml Prefilled FlexiPen (50mg Retatrutide)
• 20 x Pen Needles
• Instruction leaflet

Research Disclaimer ( Remedium Retatrutide 50mg Pen )

For laboratory and research use only.
Not intended for human consumption, medical use, or therapeutic application.

What is Retatrutide?

Retatrutide is a next-generation triple agonist peptide commonly researched for its interaction with GLP-1, GIP, and glucagon receptor pathways involved in metabolism, appetite regulation, and energy-balance studies.